SIG.AX Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: March 23, 2026
Report Source: 2026 2nd Quarter Report
Sigma Healthcare Ltd. Stock Analysis SIG.AX
Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private labels. The company is headquartered in Melbourne, Victoria. The company went IPO on 2002-10-30. The Company, as a retail pharmacy franchisor, provides intellectual property and support services to a combined network of approximately 880 Australian Franchise Network stores operating under a suite of core franchise brands including Chemist Warehouse, My Chemist, Amcal and Discount Drug Stores. The company also partly owns around 50 retail pharmacies in New Zealand, 10 retail pharmacies in Ireland and two retail pharmacies in Dubai, and 10 retail stores in China through services agreements with local companies. The Company, as a full-line wholesaler and distributor, supplies and delivers prescription products (including Pharmaceutical Benefits Scheme medicines), over the counter (OTC) and front of store (FOS) products to over 3,500 pharmacy customers. Its wholesale customers include the Retail Network as well as independent pharmacies in Australia.
Read More Sigma Healthcare Ltd (SIG.AX) Chart
Key Statistics of Sigma Healthcare Ltd (SIG.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD2.90Volume
9.95MP/E Ratio (TTM)
61.9852 Week Range
Market Cap
32.50BAvg. Volume
3.33MDividend Yield
3.66%Financial Metrics & Statements of Sigma Healthcare Ltd (SIG.AX)
FAQ's for Sigma Healthcare Ltd (SIG.AX)
- According to Musaffa’s Shariah screening methodology, Sigma Healthcare Ltd (SIG.AX) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.